francine blumental de abreu - PHL © Elysio - FUNDAÇÃO ANTÔNIO ...

243
Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative
Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis
Colon Rectum 1991; 34:424-5.
Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for
hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome)
proposed by the International Collaborative group on HNPCC.
Gastroenterology 1999; 116:1453-6.
Vasen HF, Stormorken A, Menko FH, et al. MSH2 mutation carriers are at
higher risk of câncer than MLH1 mutation carriers: a study of hereditary
nonpolyposis colorectal cancer families. J Clin Oncol 2001; 19:4074-80.
Vasen HF. Clinical description of the Lynch syndrome [hereditary
nonpolyposis colorectal cancer (HNPCC)]. Fam Cancer 2005; 4:219-25.
Venkatachalam R, Verwiel ET, Kamping EJ, et al. Identification of candidate
predisposing copy number variants in familial and early-onset colorectal
cancer patients. Int J Cancer 2011; 129:1635-42.
Venkitaraman AR. Cancer susceptibility and the functions of BRCA1 and
BRCA2. Cell 2002; 108:171-82.
Wallrapp C, Hähnel S, Müller-Pillasch F, et al. A novel transmembrane serine
protease (TMPRSS3) overexpressed in pancreatic cancer. Cancer Res
2000; 60:2602-6.
Walsh CS, Ogawa S, Scoles DR, et al. Genome-wide loss of heterozygosity
and uniparental disomy in BRCA1/2-associated ovarian carcinomas. Clin
Cancer Res 2008; 14:7645-51.